- Country: USA
- Summary: Life Tech Expifectamine 293 Transfection Kit (Ambis 2228842)
- UST Ref No: 105738763
- Deadline: 23 Aug 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: RFQ-NIAID-24-2228842
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
This notice is a Combined Synopsis/Solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-24-2228842 and the solicitation is issued as a Request for Quotes (RFQ).
This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2024-05, May 22, 2024.
The North American Industry Classification System (NAICS) code for this procurement is 325413, In-Vitro Diagnostic Substance Manufacturing, with a size standard of 1250 employees. The requirement is being competed with a brand name restriction, and without a small business set-aside.
The National Institute of Allergy and Infectious Diseases (NIAID) has a requirement for the following Brand Name Supplies:
1. ExpiFectamine 293 Transfection Kit, 10L, Product #: A14525, qty 8 each
2. Shipping and Handling, qty 1 each
The Vaccine Research Center (VRC) is to provide a mechanistic basis for
developing preventive vaccines against HIV, malaria, tuberculosis, SARS-CoV2 and therapeutic vaccines against cancer. The project aims to harness the Expi Transfection System for advanced vaccine research, focusing on accelerating the development and optimization of novel vaccine candidates. This system is integral for the production of high-yield, high-quality recombinant proteins and viral vectors, essential components in vaccine development. Thermo Fisher Sc... - Documents:
2_Terms_and_Conditions_RFQ-NIAID-24-2228842_FAR_52.pdf
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINLife Tech Expifectamine 293 Transfection Kit (Ambis 2228842) - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Life Tech Expifectamine 293 Transfection Kit (Ambis 2228842). This tender is published on USARFP under UST Ref No: 105738763 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-08-23.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
